Treatment of diseases like diabetes, cancer, multiple sclerosis or neurodegenerative diseases such as Alzheimer's still poses a tremendous challenge to modern medicine. Nanomedicine, meaning the use of nanotechnology in therapy and diagnostics, may offer promising solutions.
At the EuroNanoMedicine 2009 conference, leading experts from various disciplines such as medicine, nanotechnology, chemistry, cell biology and toxicology will present and discuss recent progress and results. The conference will take place on September 28-30, 2009 in Bled, Slovenia.
The programme will cover current topics such as targeted nanomedicine and therapeutic concepts, overcoming biological barriers, medical diagnostics and sensor devices as well as biocompatibility and toxicity of nanomaterials for medical applications. In addition to scientific issues, political and societal aspects of nanomedicine in Europe will also be adressed.
Nanomaterials are usually known from industrial applications, for example functional surface coatings. In nanomedicine, nanoparticles may be used as drug carriers, protecting the drug against degradation or enhancing uptake by the body. Surface modification of the nano transporters by introducing certain biological functionalities aims at targeted delivery, delivering the drug to the site where it is needed. This can enhance the efficiency of drug intake and decrease potential side effects.
The EuroNanoMedicine 2009 is organized by the multidisciplinary integrated project NanoBioPharmaceutics together with the projects NanoEar and MediTrans. All three projects are funded by the European Commission. Within NanoBioPharmaceutics, 25 partners including 12 university departments, six research institutes, four SMEs and three large pharmaceutical companies from 12 EU countries and the state of Israel are cooperating closely. The project is running for four years and will end in September 2010.
NanoBioPharmaceutics is aiming at the development of biodegradable nanoparticle based carrier systems to transport protein or peptide drugs safely across physiological barriers and release them at the target site within the body. For example, a drug for the treatment of Alzheimer's disease has to pass the blood brain barrier which protects the brain from unwanted or harmful substances. For diabetes patients oral intake of insulin instead of injections would mean a tremendous increase of quality of life. Additionally, NanoBioPharmaceutics investigates new cell culture test systems to compare the results with those obtained from animal testing. A long term goal is to find methods for the reduction and maybe eventually the replacement of animal experiments which are currently required for testing new medication.
At the end of the third project year, a broad range of nanocarrier systems has been designed within NanoBioPharmaceutics. These are currently being optimized and investigated for their suitability to transport drugs via oral or nasal uptake or across the blood brain barrier.Contact:
ICTM Conference 2017: Production technology for turbomachine manufacturing of the future
16.11.2016 | Fraunhofer-Institut für Produktionstechnologie IPT
Innovation Day Laser Technology – Laser Additive Manufacturing
01.11.2016 | Laser Zentrum Hannover e.V.
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy